Literature DB >> 15128417

A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.

Claus Lindbjerg Andersen1, Alicja Gruszka-Westwood, Mette Østergaard, Jørn Koch, Elisa Jacobsen, Eigil Kjeldsen, Bendt Nielsen.   

Abstract

To further characterise the genetic background of the two closely related B-lymphocytic malignancies hairy cell leukaemia (HCL), and splenic marginal zone lymphoma (SMZL) we have identified characteristic copy number imbalances by comparative genomic hybridisation (CGH). Based on these findings, areas of special interest were fine mapped, and relevant probes constructed for use in interphase-fluorescence in situ hybridisation (FISH) investigations. Thus, using the CGH data from 52 HCL and 61 SMZL patients, we identified the characteristic profiles of copy number imbalances for both diseases. These were a gain of 5q13-31 (19%) and loss of 7q22-q35 (6%) for HCL, and gain of 3q25 (28%), loss of 7q31 (16%), and gain of 12q15 (16%) for SMZL. A partial loss of 7q unusual for low-malignant B-cell diseases was found to be common to the two diseases. This loss was therefore fine mapped with BAC/PAC clones. Fine mapping revealed that in SMZL the minimal lost region covers 11.4 Mb spanning from 7q31.33 to 7q33 located between sequence tagged site (STS)-markers SHGC-3275 and D7S725. This area was distinct from the commonly deleted 7q region of myelodysplastic syndrome/acute myeloid leukaemia (MDS/AML). A FISH probe specific for the 7q region was constructed. Using this probe in an interphase-FISH investigation we showed the minimal lost 7q-region of HCL and SMZL to be one and the same. In one HCL case, this investigation furthermore showed the extent of the deleted region to be below the detection limit of CGH, whereas interphase-FISH screening of 36 chronic lymphocytic leukaemia (CLL) cases showed no deletion of the 7q area. In conclusion, we have identified characteristic profiles of copy number imbalances in HCL and SMZL and fine mapped the minimal extent of a commonly lost 7q area of special interest. We hypothesise that this region may contain (a) gene(s) important for the pathology of HCL and SMZL.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128417     DOI: 10.1111/j.1600-0609.2004.00243.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  6 in total

1.  DOCK4 deletion at 7q31.1 in a de novo acute myeloid leukemia with a normal karyotype.

Authors:  Eigil Kjeldsen; Christopher Veigaard
Journal:  Cell Oncol (Dordr)       Date:  2013-08-27       Impact factor: 6.730

2.  Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas.

Authors:  Cristina Robledo; Juan L García; Rocío Benito; Teresa Flores; Manuela Mollejo; José Ángel Martínez-Climent; Eva García; Norma C Gutiérrez; Miguel A Piris; Jesús M Hernández
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

Review 3.  Genomics of Hairy Cell Leukemia.

Authors:  Enrico Tiacci; Valentina Pettirossi; Gianluca Schiavoni; Brunangelo Falini
Journal:  J Clin Oncol       Date:  2017-02-13       Impact factor: 44.544

Review 4.  Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA.

Authors:  Jacob E Robinson; Christine E Cutucache
Journal:  Oncotarget       Date:  2018-07-06

Review 5.  The Genomics of Hairy Cell Leukaemia and Splenic Diffuse Red Pulp Lymphoma.

Authors:  David Oscier; Kostas Stamatopoulos; Amatta Mirandari; Jonathan Strefford
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

6.  Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma.

Authors:  Enrico Munari; Marianna Rinaldi; Achille Ambrosetti; Massimiliano Bonifacio; Angela Bonalumi; Marco Chilosi; Alberto Zamò
Journal:  Virchows Arch       Date:  2012-10-14       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.